Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Methods of Documentation V: CBE01:23

Methods of Documentation V: CBE

Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
Decision Making: P-value Method01:09

Decision Making: P-value Method

The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim  is also stated. These statements can act as null and alternative hypotheses:  a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Worth their weight in gray matter? A narrative review of cost-effectiveness analyses of monoclonal antibodies for Alzheimer's disease.

Alzheimer's & dementia (New York, N. Y.)·2026
Same author

Editorial: Advancements in mental health services: elucidated promising new paths along which to seek answers to improve our mental health systems.

Frontiers in health services·2026
Same author

Standard Versus Enhanced Measurement-Based Care Effectiveness for Depression (EMBED): Protocol for a Cluster Randomized Implementation-Effectiveness Trial.

Cureus·2025
Same author

Associations of cumulative hearing and vision loss with depression among U.S. adults aged 50 and older: results from the health and retirement study.

BMC psychiatry·2025
Same author

Health economic evaluations of perinatal complications with conflicting maternal-fetal interests: a scoping review protocol.

BMJ open·2025
Same author

Developing and Applying the BE-FAIR Equity Framework to a Population Health Predictive Model: A Retrospective Observational Cohort Study.

Journal of general internal medicine·2025

Related Experiment Video

Updated: Jul 5, 2026

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

A clinician's guide to correct cost-effectiveness analysis: think incremental not average.

Jeffrey S Hoch1, Carolyn S Dewa

  • 1Department of Health Policy, Management and Evaluation, Centre for Research on Inner City Health, The Keenan Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Ontario. jeffrey.hoch@utoronto.ca

Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|May 16, 2008
PubMed
Summary

Correctly reporting cost-effectiveness analysis (CEA) results is crucial for healthcare decisions. Understanding incremental cost-effectiveness ratios and incremental net benefit ensures accurate interpretation of treatment trade-offs.

More Related Videos

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Related Experiment Videos

Last Updated: Jul 5, 2026

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Area of Science:

  • Health Economics
  • Clinical Trial Analysis
  • Decision Science

Background:

  • Healthcare decision-making requires balancing costs with patient outcomes.
  • Accurate reporting of economic evaluations is essential for informed choices.
  • Scientific literature contains examples of debated cost-effectiveness analysis (CEA) reporting.

Purpose of the Study:

  • To guide the correct reporting of cost-effectiveness analysis (CEA) results.
  • To illustrate how different reporting methods impact findings and conclusions.
  • To enhance understanding of CEA interpretation for decision-makers.

Main Methods:

  • Utilized a hypothetical clinical trial to demonstrate reporting variations.
  • Reviewed high-profile scientific literature exchanges on CEA reporting.
  • Focused on the presentation of economic results and their influence on conclusions.

Main Results:

  • Key decisions hinge on the trade-offs between additional costs and outcomes.
  • Incremental cost-effectiveness ratio (ICER) and incremental net benefit (INB) are critical measures.
  • These measures quantify the value proposition of new interventions.

Conclusions:

  • Accurate CEA reporting is vital for healthcare providers and decision-makers.
  • Misleading CEA results can negatively impact adoption of new treatments or programs.
  • A foundational understanding of CEA methods and interpretation is necessary for consumers.